BY OUR PLATFORMS
BY THERAPEUTIC AREA
01 December 2022 - 30 November 2025
The project will use patient derived-iPSC and CRISPR-edited human IPSC to develop a novel three-dimensional microfluidic system for drug discovery.
01 October 2022 - 30 September 2027
The EdiGenT consortium will work to develop a new generation of more efficient gene correction tools based on the CRISPR/Cas9 system, and non-viral delivery strategies for gene therapy.
01 January 2022 - 30 June 2023
ZeBYTE aims at using artificial intelligence technologies along the whole target discovery process.
01 August 2021 - 01 August 2023
A cutting-edge gene-editing platform to generate complex disease models to test innovative therapeutic approaches.
01 April 2021 - 31 March 2024
The ROBO-FISH consortium will develop and validate injection and imaging robots to automate oncology drug screening in zebrafish to mimic human disease.
01 December 2020 - 30 November 2023
CARDIOMYO combines three complementary approaches: 1) high content phenotypic in vitro cardiac assays 2) a novel in vivo cardiovascular phenotyping using zebrafish and 3) drug discovery chemistry
01 September 2020 - 31 August 2023
Our purpose is to isolate nanobodies that bind cancer stemm cells and have a direct cytotoxic effect on them, or could act as carriers of cytotoxic drugs specifically towards them.
01 January 2020 - 31 December 2023
SCilS is training a new generation of scientists to characterise ciliopathies, an increasingly important and diverse class of inherited diseases.
01 January 2020 - 31 December 2024
REANIMA aims to deliver new therapies for heart regeneration, thereby reverting the conditions that lead to heart failure.
01 October 2019 - 30 September 2023
The EU-funded ZENITH project is preparing a new generation of scientists for interdisciplinary collaboration on pressing neuroscience challenges utilising the zebrafish model system.
01 June 2019 - 31 May 2021
We propose the development of a high-throughput preclinical platform using the zebrafish model to find suitable treatments for heart regeneration after ischemia.
01 December 2018 - 31 May 2021
The concept of the InnoTCM project is to apply an innovative approach to profiling the TCM herb extracts by using Zebrafish as a model organism in High Throughput Screening (HTS) manner.
06 September 2018 - 31 January 2022
We aim to implement cardiac injury models in zebrafish and to use them to identify genes involved in heart regeneration, with a focus on genes impairing cardiomyocyte dedifferentiation/proliferation.
01 April 2018 - 31 March 2021
ZF-Glioma's aim was to model human glioma (brain cancer) in zebrafish to screen for tyrosine kinase inhibitors (TKIs) with the potential to treat this devastating disease.
01 April 2017 - 31 March 2019
Within this project ZeClinics developed ZeCardio®, a unique, fully automated, robotic and software-driven cardiovascular screening platform.
01 January 2017 - 31 December 2017
The objective of the project is to analyze libraries of molecules provided by collaborating entities with a view to discovering molecules with cardioprotective and anti-tumor therapeutic actions.
Please leave your details in the form below.